JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3003 MDV3100 (Enzalutamide)
28 Citation

Target: Androgen Receptors

Summary: androgen receptor antagonist

≥23.22 mg/mL
A3010 MK-2206 dihydrochloride
52 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3013 PD0325901
25 Citation

Summary: MEK inhibitor

≥24.1 mg/mL
A3014 BGJ398
1 Citation

Target: FGFR

Summary: FGFR inhibitor ,potent and selective

insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
A4002 IU1
1 Citation

Summary: Usp14 inhibitor

insoluble in H2O; ≥10.9 mg/mL
A4006 MK-0752
1 Citation

Summary: γ-secretase inhibitor

≥22.15 mg/mL
A2574 Aprotinin
8 Citation

Target: Trypsin|Chymotrypsin|Kallikrein|Trypsinogen

Summary: serine protease inhibitor

≥195 mg/mL
A2600 (-)-Epigallocatechin gallate (EGCG)
4 Citation

Target: BACE

Summary: major catechin component derived from green tea

≥22.9 mg/mL
A2602 Calpain Inhibitor I, ALLN
5 Citation

Target: Cathepsins|Calpains

Summary: Calpain I/II/ B/L inhibitor
A4054 17-AAG (KOS953)
3 Citation

Summary: Hsp90 inhibitor

≥24.95 mg/mL